SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-064827
Filing Date
2021-03-02
Accepted
2021-03-02 10:22:21
Documents
5
Effectiveness Date
2021-03-02

Document Format Files

Seq Description Document Type Size
1 S-8 d24654ds8.htm S-8 41065
2 EX-5.1 d24654dex51.htm EX-5.1 11170
3 EX-23.1 d24654dex231.htm EX-23.1 1731
4 GRAPHIC g24654dsp6logo.jpg GRAPHIC 3160
5 GRAPHIC g24654dsp7logo.jpg GRAPHIC 1855
  Complete submission text file 0001193125-21-064827.txt   62231
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-253776 | Film No.: 21701617
SIC: 2834 Pharmaceutical Preparations